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All patients had normal left ventricular cavity dimensions. Five benign hypertensives and malignant hypertensives with a previous history of hypertension had significant thickening of the septum and posterior wall. In eight malignant hypertensives without a previous history wall thicknesses were normal. The absence of ventricular hypertrophy in some cases of malignant hypertension suggests that it is sometimes of rapid onset and not preceded by a non-malignant phase.
Although fractional shortening and peak Vcf were normal in all the hypertensives, diastolic left ventricular function was frequently abnormal with delayed mitral valve opening, reduced peak rate of filling, and outward endocardial motion during isovolumic relaxation. Malignant hypertensives showed a cavity shape change during isovolumic contraction, and in those without a previous history the aortic second heart sound occurred earlier. The abnormalities of function are probably the result of a combination of factors including pressure overload, abnormal myocardial properties, and myocardial ischaemia, either regional or generalised and secondary to arteriolitis.
Malignant hypertension is a rare disorder which carries a high mortality and morbidity. Heart failure may be a presenting feature and was a common cause of death before the advent of effective hypotensive therapy. ' Echocardiographic studies in benign hypertension2 3 Echocardiographs were digitised as previously described by Gibson and Brown,5 using a Summagraphics digitiser and a Prime 3000 computer system. From these records the following measurements were made ( Fig. 1 ).
(1) End-diastolic (EDD) and end-systolic (ESD) cavity dimensions in cm. Fractional shortening was derived as (EDD-ESD)/EDD. (2) Peak normalised rate of reduction of dimension during systole (peak Vcf).
(3) Peak rate of increase in dimension during early diastole (cm/s).
(4) Early diastolic filling period, defined as the period from minimal left ventricular dimension to the time of reduction in filling to 20% of its peak value (ms).
(5) Time intervals in ms (a) Q wave of the electrocardiogram to aortic second heart sound (A2), corrected for heart rate (QA2 + heart rate x 0-21 (men) or 0.2 (women))6 and expressed as QA21 (b) A2 to minimum dimension was taken as negative if minimum dimension followed A2 and positive if it preceded A2. (c) Minimum dimension to mitral valve opening.
(6) Change in dimension between minimum dimension and mitral valve opening (isovolumic relaxation) expressed as a percentage of the total dimension change during the cardiac cycle.
(7) Change in left ventricular dimension during the time of inscription of the upstroke of the apexcardiogram (isovolumic contraction), expressed as a percentage of the total dimension change during the cardiac cycle.7
STATISTICAL METHOD
Normally distributed variables are quoted as mean with one standard deviation and those not normally distributed as mean and range. Student's t test and the Mann-Whitney U test were used to test differences between groups where appropriate.
Results

CLINICAL
All normal subjects had normal electrocardiograms and chest radiographs. The mean heart rate in the normal subjects and benign hypertensives was similar (71 and 76 per minute, respectively). Both groups with malignant hypertension had a higher heart rate (previous hypertensive history 85 per minute and no previous history 89 per minute). All patients with benign hypertension, four of the malignant hypertensives with, and four without a previous history, had electrocardiographic evidence of left ventricular hypertrophy on voltage criteria and all but one each of the latter two groups had ST-T wave changes. The cardiothoracic ratio varied from 42 to 60% in hypertensives; it was greater in the malignant hypertensives with a previous hypertensive history (57%) than in those without (47%). Serum urea concentration was raised above 10 mmol/l (60 mg/100 ml) in seven malignant hypertensives.
LEFT VENTRICULAR DIMENSIONS (Table 1) The left ventricular cavity dimensions in systole and diastole were normal in all three groups of hypertensives. Seven of the malignant hypertensives with no previous history of hypertension had normal posterior wall and septal thicknesses, and one patient had raised values (Fig. 2) . The other two groups of hypertensives showed increased thickness of the posterior wall and septum which were significantly different from normal (benign p<0.01, malignant p<0001 antecedent history had a thickened septum relative to the posterior wall (ratio septum to posterior wall 1 5: 1 and 1 3:1).
LEFT VENTRICULAR FUNCTION (Table 2) In most hypertensives, A2 preceded minimum dimension. There was a wide range of values in the malignant groups; in two of the five with a previous history A2 followed minimum dimension but in those without a previous history A2 occurred significantly tension. Though these abnormalities are usually found in the kidney, other tissues, including heart,' essential hypertension and aortic valve disease is may show fibrinoid necrosis of arterioles and prolifercapable of maintaining adequate cardiac com-ative endarteritis with resultant ischaemia and focal pensation for a long time.
necrosis.
We have confirmed that patients with severe
Computerised analysis of the M-mode echocardio- Treatment should not be delayed in malignant hypertension, and in some cases the blood pressure was therefore reduced by beta-adrenergic blockade before investigation. This would not affect myocardial hypertrophy and was unlikely to have greatly influenced function, as peak Vcf and fractional shortening remained normal and a similar therapeutic regimen did not induce cavity shape changes in benign hypertensives.
It is not surprising that patients with malignant hypertension have impaired left ventricular function; the combination of increased work from pressure overload, abnormal ventricular stiffness, impaired perfusion from arteriolitis, and areas of focal necrosis readily explains myocardial dysfunction and the high incidence of heart failure previously reported.' The role of coronary atherosclerosis is uncertain but may be important as the greatly increased myocardial oxygen demand may exceed blood flow through narrowed vessels which would not normally limit supply. The absence of wall and septal thickening in some patients with malignant hypertension suggests that this phase is sometimes relatively rapid in onset without a preceding benign phase. 
